Measuring Specific, Rather than Generalized, Cognitive Deficits and Maximizing Between-Group Effect Size in Studies of Cognition and Cognitive Change

Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4

Abstract

While cognitive impairment in schizophrenia is easy to demonstrate, it has been much more difficult to measure a specific cognitive process unconfounded by the influence of other cognitive processes and noncognitive factors (eg, sedation, low motivation) that affect test scores. With the recent interest in the identification of neurophysiology-linked cognitive probes for clinical trials, the issue of isolating specific cognitive processes has taken on increased importance. Recent advances in research design and psychometric theory regarding cognition research in schizophrenia demonstrate the importance of (1) maximizing between-group differences via reduction of measurement error during both test development and subsequent research and (2) the development and use of process-specific tasks in which theory-driven performance indices are derived across multiple conditions. Use of these 2 strategies can significantly advance both our understanding of schizophrenia and measurement sensitivity for clinical trials. Novel data-analytic strategies for analyzing change across multiple conditions and/or multiple time points also allow for increased reliability and greater measurement sensitivity than traditional strategies. Following discussion of these issues, trade-offs inherent to attempts to address psychometric issues in schizophrenia research are reviewed. Finally, additional considerations for maximizing sensitivity and real-world significance in clinical trials are discussed.

Authors and Affiliations

Steven M. Silverstein

Keywords

Related Articles

Approaches for Unraveling the Joint Genetic Determinants of Schizophrenia and Bipolar Disorder

Since Emil Kraepelin proposed in 1919 that dementia praecox (schizophrenia) be differentiated from manic depression (bipolar disorder), the concept of nosological dichotomy has greatly influenced the diagnosis, treatment...

Implications of Clinical Trial Design on Sample Size Requirements

The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison group...

Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework

The evolutionary origins of one of the most dramatic and seemingly deleterious behavioral phenotypes, the syndrome known as schizophrenia, are mysterious. Schizophrenia occurs in all cultures and is inherited. Although m...

Current Psychopathological Issues in Psychosis: Towards a Phenome-wide Scanning Approach

Supported in part by a grant of the Health Department of the Navarre Government, Spain (55/2007).

The Translation of Cognitive Paradigms for Patient Research

Many cognitive tasks have been developed by basic scientists to isolate and measure specific cognitive processes in healthy young adults, and these tasks have the potential to provide important information about cognitiv...

Download PDF file
  • EP ID EP683276
  • DOI  10.1093/schbul/sbn032
  • Views 73
  • Downloads 0

How To Cite

Steven M. Silverstein (). Measuring Specific, Rather than Generalized, Cognitive Deficits and Maximizing Between-Group Effect Size in Studies of Cognition and Cognitive Change. Schizophrenia Bulletin, 34(4), -. https://europub.co.uk./articles/-A-683276